Editorial & Opinion
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD -genotype variants and P-uracil concentrations.
| العنوان: | Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD -genotype variants and P-uracil concentrations. |
|---|---|
| المؤلفون: | Paulsen NH; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine Department of Public Health, University of Southern Denmark, Odense, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vojdeman FJ; Department of Clinical Biochemistry, Holbaek Hospital, Holbaek, Denmark., Plomgaard P; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Andersen SE; Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark., Ramlov A; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Bertelsen B; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Rossing M; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Nielsen CG; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark., Hoffmann-Lücke E; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark., Greibe E; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark., Spangsberg Holm H; Department of Oncology, Odense University Hospital, Odense, Denmark., Nielsen HH; Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark., Lolas IBY; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark., Madsen JS; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Bergmann ML; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark., Mørk M; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark., Fruekilde PBN; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark., Bøttger P; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Petersen PC; Department of Oncology, Zealand University Hospital, Roskilde, Denmark., Nissen PH; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.; Denmark and Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark., Feddersen S; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Bergmann TK; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Department of Regional Health Research, University of Southern Denmark, Esbjerg, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Damkier P; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.; Clinical Pharmacology, Pharmacy and Environmental Medicine Department of Public Health, University of Southern Denmark, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark. |
| المصدر: | Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Nov; Vol. 61 (11), pp. 1400-1405. Date of Electronic Publication: 2022 Oct 18. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medical Journals Sweden AB Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2024- : [Uppsala, Sweden] : Medical Journals Sweden AB Original Publication: Stockholm, Sweden : Acta Oncologica, [1987- |
| مواضيع طبية MeSH: | Dihydrouracil Dehydrogenase (NADP)*/genetics , Neoplasms*/epidemiology , Neoplasms*/genetics, Humans ; Uracil ; Prevalence ; Genotype ; Phenotype ; Denmark/epidemiology ; Fluorouracil |
| المشرفين على المادة: | EC 1.3.1.2 (Dihydrouracil Dehydrogenase (NADP)) 56HH86ZVCT (Uracil) U3P01618RT (Fluorouracil) |
| تواريخ الأحداث: | Date Created: 20221018 Date Completed: 20221207 Latest Revision: 20230303 |
| رمز التحديث: | 20230304 |
| DOI: | 10.1080/0284186X.2022.2132117 |
| PMID: | 36256873 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1651-226X |
|---|---|
| DOI: | 10.1080/0284186X.2022.2132117 |